INTEGRATED CORE STRATEGIES (US) LLC - 18 Feb 2026 SCHEDULE 13G Report for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol
JSPR
Shares outstanding
28,086,431 shares
Disclosed Ownership
1,629,013 shares
Ownership
5.8%
Form type
SCHEDULE 13G
Filing time
25 Feb 2026, 16:47:25 UTC
Date of event
18 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 5.8% ownership in Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR) on 18 Feb 2026."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR).
  • Disclosed ownership: 5.8%.
  • Date of event: 18 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 25 Feb 2026, 16:47.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.8% 1,624,076 0 1,624,076 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.8% 1,629,013 0 1,629,013 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.8% 1,629,013 0 1,629,013 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.8% 1,629,013 0 1,629,013 /s/ Israel A. Englander Israel A. Englander

Sponsored